BackAbbott Laboratories Overview

Abbott Laboratories Accounts Payable

Track Abbott Laboratories's accounts payable ($4.8B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$4.79B
11.33% YoYΔ $488.00M vs prior year quarter

Peer average / median

Loading

Abbott Laboratories Accounts Payable History

Loading

Abbott Laboratories vs. peers: Accounts Payable Comparison

Loading

Abbott Laboratories Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Abbott Laboratories (ABT) FAQ

As of the most recent data (June 2026), ABT shows a accounts payable of $4.8B. That compares with $4.3B in the prior-year period — up 11.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ABT's accounts payable is now $4.8B (was $4.3B) — a 11.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Abbott Laboratories is outperforming or lagging.

Tracking ABT's accounts payable over time shows whether Abbott Laboratories is scaling, shrinking, or reshaping that part of the business. The current reading is $4.8B That compares with $4.3B in the prior-year period — up 11.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Abbott Laboratories's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $4.8B) with ownership activity and broader fundamentals.

Abbott Laboratories's accounts payable is $4.8B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.